PhaseBio Pharmaceuticals Inc. (PHAS) rose 5.72% or 0.18 to $3.23. It is approximately 20161 shares traded, which is 27.96% compare to the average total volume 72113. The market cap of PHAS is $79.25 million. The year to date change is -33.08%. The 52 week price range is from $2.55 to $6.0. Price of PHAS have changed 2.00% during last week. It have changed -39.88% over last month, -38.80% over last 3 months, -38.80% over last 6 months and -38.80% over one year.
The 52-week High is 6.0. It is 85.76% from the current price. The 52-week Low is 2.55. It is -21.05% from current price.
There are some statistics of PHAS. It is has market cap $79.25 million. The share outstanding is 24.50 million. The average volume is 72113. The percent of top 15 Institution holding is 0.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PHAS is 17.05%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PHAS is -72.08%.